Pleomorphic giant cell carcinoma of the esophagus with coexpression of cytokeratin and vimentin and neuroendocrine differentiation

Citation
Jf. Mosnier et Jg. Balique, Pleomorphic giant cell carcinoma of the esophagus with coexpression of cytokeratin and vimentin and neuroendocrine differentiation, ARCH PATH L, 124(1), 2000, pp. 135-138
Citations number
9
Categorie Soggetti
Research/Laboratory Medicine & Medical Tecnology","Medical Research Diagnosis & Treatment
Journal title
ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE
ISSN journal
00039985 → ACNP
Volume
124
Issue
1
Year of publication
2000
Pages
135 - 138
Database
ISI
SICI code
0003-9985(200001)124:1<135:PGCCOT>2.0.ZU;2-Z
Abstract
A pleomorphic (giant cell) carcinoma of the esophagus is reported in a 52-y ear-old man who had dysphagia and weakness. The 8-cm-high vegetating tumor consisted of solid sheets of poorly cohesive epithelioid cells broken into clusters by strands of stroma. Numerous giant cells showing phagocytic phen omenon were present. Immunochemical analyses demonstrated the epithelial or igin of the neoplasm, although most of the tumor cells strongly expressed v imentin. Numerous tumor cells expressed synaptophysin. Neurosecretory granu les were detected in some tumor cells on electron microscopic examination. The patient died 4 months after he became symptomatic. As far as we can asc ertain, this is the first case report describing a pleomorphic carcinoma ar ising in the esophagus. This poorly differentiated carcinoma might be of ne uroendocrine differentiation. In the esophagus, pleomorphic carcinoma must be distinguished from polypoid tumors such as carcinosarcoma and malignant melanoma.